This year has been one for the books in medicine. From Ozempic’s expanded role in protecting failing kidneys to long‑acting HIV prevention and the first new non‑opioid painkiller in decades, 2025’s drug approvals have rewritten clinical playbooks worldwide. In this feature, we explore the new medicines that aren’t just ticking boxes in regulatory filings — they are reshaping how doctors treat chronic disease, pain, infection and more with real‑world impact backed by study data, clinical trials and expert buzz.
No comments:
Post a Comment